2022年12月22日

Healthtech啟動WonDRx種子輪資金來自企業催化劑WonDRx旨在利用資金來為所有利益相關者提供基於人工智能醫療解決方案風險催化劑是印度第一家綜合性孵化器。投資250美元- 150萬美元的早期創業公司有潛力創造持久的價值在很長一段時間。風險資本催化劑帶來致命的組合,指導和商業網絡,幫助投資企業獲得成功。他們的創新提供了價值通過其天使網絡創業,資金、社區服務和聯合辦公設施。想象下次去你的醫生的處方和接收數字拷貝你的移動以及物理手寫的副本。你另外電子版包含重要的錄音劑量和其他重要的口頭指令由醫生,以確保你不會犯錯。你的電子版也將幫助你獲得教育的視頻你患有健康問題。不僅如此,你可以看到各種各樣的醫療服務提供者在你周圍你可以立即聯係誰。WonDRx使這樣一個夢想成真,Wonder-Rx(發音),一個國家的藝術小說&創新HealthTech啟動與視覺的“供給與需求”消費者/病人和衛生保健提供者之間通過數據驅動的方法。最近,風險資金投資了一筆金額未公開的催化劑在創業的種子資金。 Deriving its inspiration from the Rx written on prescriptions by doctors as an abbreviated form of the Latin for the word ‘receipt’, WonDRx aims to develop a holistic ecosystem that facilitates quick and seamless information exchange in the world of healthcare. Recently, Venture Catalysts invested in the seed round of funding organized by the start-up. The Health-tech sector is one of the most high-potential domains today, registering a double digit growth every year. Yet, the “demand to supply” journey still remains chaotic, and no transactions are completed until the physical Rx paper is received by the healthcare service provider. WonDRx aims to fully optimize this model through an infusion of technology at every step, right from the first interaction to the last execution of transaction. The innovation introduced by WonDRx is unique. While the doctor continues to hand-write every Rx like before, with the help of WonDRx digital pen and Smart Rx paper – every written Rx is instantly digitized and the digital Rx copy is available to the Doctor, Patient and various healthcare providers (post Patient consent). “At Venture Catalysts, we have always tried to support start-ups that fill a great need gap which also has a positive impact on the society at large. We have also recently focused our attention to start-ups dedicated emerging within the Health-tech space, considering the immense prospects of the domain. WonDRx has a great potential and we hope this association will help them build the fastest growing Health-tech organization in India. The market is still untapped and considering WonDRx’s stellar offering, I believe they can be the leaders in this space within a very short time.” says Dr Apoorv Ranjan Sharma, Founder of Venture Catalysts. Approximately 800 thousand doctors are writing prescriptions every day. The sector is also accruing a market of around 8 Billion USD from product subscription. More than 8 million Rx are transacted each day at various healthcare providers and about 500 Billion USD value worth of services is transacted through prescriptions alone. In fact, this document with an Rx written on top, drives transactions over billions of dollars spent by Pharma and Healthcare companies to reach out to various healthcare stakeholders. "Healthcare has been one of the primary themes of investment at NB Ventures. Digitizing the medical records will have a positive outcome for doctors, patients, insurance firms and pharma companies. The data generated will enable real-time motoring of major disease, enabling formulating policies etc. in the future. I believe WondRX has huge potential in India as well in other markets like GCC and Africa. I look forward to integrating their offering with my other portfolio companies in the healthcare space." adds Neelesh Bhatnagar Chief Executive NB Ventures Limited WonDRx will offer three integrated Apps- WonDRx Doctor App, WonDRx Consumer App (For patients/consumers) and WonDRx Provider App (For any healthcare provider) to create a holistic, tech driven service ecosystem. Backed by a strong technology framework powering an innovative product perfectly addressing a pressing need, WonDRx has the potential to ‘become a credible Identity in Integrated Healthcare space by 2024 while establishing the most impactful Healthcare collaboration platform’ as per Pankaj Sindhu, serial entrepreneur and Founder, WonDRx. Share this article: